Bangladesh · Delayed Price · Currency is BDT Ambee Pharmaceuticals Statistics
Total Valuation
DSE:AMBEEPHA has a market cap or net worth of BDT 1.82 billion. The enterprise value is 2.38 billion.
| Market Cap | 1.82B |
| Enterprise Value | 2.38B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Nov 23, 2025 |
Share Statistics
DSE:AMBEEPHA has 2.40 million shares outstanding.
| Current Share Class | 2.40M |
| Shares Outstanding | 2.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 77.25% |
| Owned by Institutions (%) | n/a |
| Float | 545,941 |
Valuation Ratios
The trailing PE ratio is 276.18.
| PE Ratio | 276.18 |
| Forward PE | n/a |
| PS Ratio | 9.94 |
| PB Ratio | 53.03 |
| P/TBV Ratio | 53.03 |
| P/FCF Ratio | 347.37 |
| P/OCF Ratio | 90.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 187.23, with an EV/FCF ratio of 453.43.
| EV / Earnings | 360.50 |
| EV / Sales | 12.97 |
| EV / EBITDA | 187.23 |
| EV / EBIT | n/a |
| EV / FCF | 453.43 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 19.20.
| Current Ratio | 0.84 |
| Quick Ratio | 0.44 |
| Debt / Equity | 19.20 |
| Debt / EBITDA | 51.93 |
| Debt / FCF | 125.76 |
| Interest Coverage | 103.40 |
Financial Efficiency
Return on equity (ROE) is 20.45% and return on invested capital (ROIC) is 0.67%.
| Return on Equity (ROE) | 20.45% |
| Return on Assets (ROA) | 0.44% |
| Return on Invested Capital (ROIC) | 0.67% |
| Return on Capital Employed (ROCE) | 13.78% |
| Weighted Average Cost of Capital (WACC) | 1.67% |
| Revenue Per Employee | 387,279 |
| Profits Per Employee | 13,933 |
| Employee Count | 474 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.39 |
Taxes
In the past 12 months, DSE:AMBEEPHA has paid 2.20 million in taxes.
| Income Tax | 2.20M |
| Effective Tax Rate | 24.96% |
Stock Price Statistics
The stock price has increased by +5.00% in the last 52 weeks. The beta is -0.36, so DSE:AMBEEPHA's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | +5.00% |
| 50-Day Moving Average | 743.61 |
| 200-Day Moving Average | 782.89 |
| Relative Strength Index (RSI) | 48.98 |
| Average Volume (20 Days) | 500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:AMBEEPHA had revenue of BDT 183.57 million and earned 6.60 million in profits. Earnings per share was 2.75.
| Revenue | 183.57M |
| Gross Profit | 85.24M |
| Operating Income | 5.25M |
| Pretax Income | 8.80M |
| Net Income | 6.60M |
| EBITDA | 12.27M |
| EBIT | 5.25M |
| Earnings Per Share (EPS) | 2.75 |
Balance Sheet
The company has 103.46 million in cash and 660.32 million in debt, with a net cash position of -556.86 million or -232.02 per share.
| Cash & Cash Equivalents | 103.46M |
| Total Debt | 660.32M |
| Net Cash | -556.86M |
| Net Cash Per Share | -232.02 |
| Equity (Book Value) | 34.40M |
| Book Value Per Share | 14.33 |
| Working Capital | -113.29M |
Cash Flow
In the last 12 months, operating cash flow was 20.25 million and capital expenditures -14.99 million, giving a free cash flow of 5.25 million.
| Operating Cash Flow | 20.25M |
| Capital Expenditures | -14.99M |
| Depreciation & Amortization | 7.02M |
| Net Borrowing | 31.42M |
| Free Cash Flow | 5.25M |
| FCF Per Share | 2.19 |
Margins
Gross margin is 46.43%, with operating and profit margins of 2.86% and 3.60%.
| Gross Margin | 46.43% |
| Operating Margin | 2.86% |
| Pretax Margin | 4.79% |
| Profit Margin | 3.60% |
| EBITDA Margin | 6.68% |
| EBIT Margin | 2.86% |
| FCF Margin | 2.86% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 32.37% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.13% |
| Earnings Yield | 0.36% |
| FCF Yield | 0.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2014. It was a forward split with a ratio of 1.2.
| Last Split Date | May 29, 2014 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
DSE:AMBEEPHA has an Altman Z-Score of 1.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 4 |